<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87-nanomaterials-10-01072">
 <label>87.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jung</surname>
    <given-names>S.Y.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>E.Y.</given-names>
   </name>
   <name>
    <surname>Seo</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.L.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>H.L.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>S.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Heterologous primeâ€“boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East Respiratory syndrome coronavirus</article-title>
  <source>Vaccine</source>
  <year>2018</year>
  <volume>36</volume>
  <fpage>3468</fpage>
  <lpage>3476</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.04.082</pub-id>
  <?supplied-pmid 29739720?>
  <pub-id pub-id-type="pmid">29739720</pub-id>
 </element-citation>
</ref>
